Efficient syntheses of fluorinated leucines, valines and alanines are described. The synthetic routes provide expedient access to various C/N/D isotopologues requiring solely readily available and inexpensive isotope containing reagents such as NaBD, carbon-C dioxide and sodium azide-1-N. The lightly fluorinated leucines and valines were found to be good substrates for cell-free protein expression and even 3-fluoroalanine, which is highly toxic to bacteria , could be incorporated into proteins this way. F-NMR spectra of the protein GB1 produced with these amino acids showed large chemical shift dispersions. Particularly high incorporation yields and clean F-NMR spectra were obtained for GB1 produced with valine residues, which had been synthesized with a single fluorine substituting a hydrogen stereospecifically in one of the methyl groups.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d2ob00145d | DOI Listing |
J Neurochem
January 2025
Associate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, Caparica, Portugal.
Neurotransmitter:sodium symporters (NSS) reuptake neurotransmitter molecules from the synaptic space through Na-coupled transport. They are thought to work via the alternating access mechanism, exploring multiple configurations dictated by the binding of substrates and ions. Much of the current knowledge about these transporters has been derived from examining the structure of the Leucine Transporter (LeuT), a bacterial counterpart to human NSSs.
View Article and Find Full Text PDFBiochemistry
June 2024
ARC Centre of Excellence for Innovations in Peptide & Protein Science, Research School of Chemistry, Australian National University, Canberra, ACT 2601, Australia.
Global substitution of leucine for analogues containing CHF instead of methyl groups delivers proteins with multiple sites for monitoring by F nuclear magnetic resonance (NMR) spectroscopy. The 19 kDa peptidyl-prolyl isomerase B (PpiB) was prepared with uniform high-level substitution of leucine by (2,4)-5-fluoroleucine, (2,4)-5-fluoroleucine, or 5,5'-difluoroleucine. The stability of the samples toward thermal denaturation was little altered compared to the wild-type protein.
View Article and Find Full Text PDFBiochemistry
June 2024
ARC Centre of Excellence for Innovations in Peptide & Protein Science, Research School of Chemistry, Australian National University, Canberra, ACT 2601, Australia.
Proteins produced with leucine analogues, where CHF groups substitute specific methyl groups, can readily be probed by F NMR spectroscopy. As CF and CH groups are similar in hydrophobicity and size, fluorinated leucines are expected to cause minimal structural perturbation, but the impact of fluorine on the rotational freedom of CHF groups is unclear. We present high-resolution crystal structures of peptidyl-prolyl - isomerase B (PpiB) prepared with uniform high-level substitution of leucine by (2,4)-5-fluoroleucine, (2,4)-5-fluoroleucine, or 5,5'-difluoroleucine.
View Article and Find Full Text PDFAAPS PharmSciTech
April 2024
Department of Mechanical Engineering, University of Alberta, Edmonton, Alberta, T6G1H9, Canada.
Pressurized metered dose inhalers (pMDIs) require optimized formulations to provide stable, consistent lung delivery. This study investigates the feasibility of novel rugose lipid particles (RLPs) as potential drug carriers in pMDI formulations. The physical stability of RLPs was assessed in three different propellants: the established HFA-134a and HFA-227ea and the new low global-warming-potential (GWP) propellant HFO-1234ze.
View Article and Find Full Text PDFOrg Lett
March 2024
Drug Substance Development, GSK, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
A highly enantioselective organocatalytic aza-Michael addition of 4-nitro-pyrazole to ethyl ()-2,2-difluoro-5-oxopent-3-enoate has been developed. This reaction enabled a concise, four-step, stereoselective synthesis of highly functionalized 3,3-difluoro-4-pyrazolo-piperidine GSK3901383A, a key intermediate for the synthesis of a leucine-rich repeat kinase 2 inhibitor API. Computational analysis provided insight into the steric requirements of the catalytic system, enabling rational selection of a highly selective catalyst.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!